Nodular lichen myxoedematous: a new adverse event associated with ustekinumab

• DOI: 10.1111/ajd.13291
• Publication Date: 2020-04-14T11:58:49Z
• Authors: Trinidad Montero‐...; Antonio Martinez‐...; Carlos Cuenca‐Bar...; Aurelio Martin‐Ca...; Alejandro Molina‐...; Salvador Arias‐Sa...
• Keywords: Ustekinumab; Etiology

Abstract Nodular lichen myxoedematosus is a localised form of myxoedematosus, chronic idiopathic cutaneous mucinosis known aetiology. Ustekinumab human interleukin‐12/23 monoclonal antibody that could directly or indirectly increase mucin production. Herein, we report for the first time case nodular associated with ustekinumab.